Developing evidence-based standards for the administration of oral anticancer medicines
Intended for healthcare professionals
Evidence and practice    

Developing evidence-based standards for the administration of oral anticancer medicines

Janice Patricia Richmond Advanced nurse practitioner, Oncology Department, Letterkenny University Hospital, Letterkenny, Republic of Ireland
Mary Grace Kelly Research nurse oncology, Letterkenny University Hospital, Letterkenny, Republic of Ireland
Patrick Jeremiah Murphy Network manager, Health Research Board Primary Care Clinical Trials Network Ireland, University of Galway, Republic of Ireland
Andrew William Murphy Director, Health Research Board Primary Care Clinical Trials Network Ireland and foundation professor, Discipline of General Practice, School of Medicine, University of Galway, Republic of Ireland
Alison Johnston Clinical nurse manager information technology and data management, Letterkenny University Hospital, Letterkenny, Republic of Ireland

Why you should read this article:
  • To enhance your knowledge of the safe administration of oral anticancer medicines

  • To appreciate the importance of monitoring patients taking oral anticancer medicines

  • To read about the development of new standards for the administration of oral anticancer medicines

Cancer treatments have undergone a paradigm shift with the development and rapid growth of the use of oral anticancer treatment, particularly within the past ten years. Responsibility for administration of oral anticancer medicines has largely been devolved from the oncology team to the patient and their caregivers. However, there are longstanding safety concerns about people receiving oral anticancer medicines, therefore patient management and safety is of paramount importance. The authors reviewed the evidence and guidelines on administration of oral anticancer medicines, which encompasses patient management, then formulated new standards for clinical practice, which are reported in the article.

Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1828

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

janicep.richmond@hse.ie

Conflict of interest

This work was supported by the Irish Cancer Society (Grant number CNRA19RIC) in partnership with the Health Research Board, the National Cancer Control Programme and the Office of the Nursing and Midwifery Services Director. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript

Richmond JP, Kelly MG, Murphy PJ et al (2022) Developing evidence-based standards for the administration of oral anticancer medicines. Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1828

Published online: 24 November 2022

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more